Cargando…

Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli

BACKGROUND: Bacteriophages are viruses that attack bacteria and lead to their lysis in an efficient and highly specific manner. These natural enemies of bacteria were used as therapeutic agents before the advent of antibiotics. Currently, with the rapid spread of multi-drug resistant bacteria, phage...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahmani, Rana, Zarrini, Gholamreza, Sheikhzadeh, Farzam, Aghamohammadzadeh, Naser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377167/
https://www.ncbi.nlm.nih.gov/pubmed/25834712
http://dx.doi.org/10.5812/jjm.17744
_version_ 1782363858023743488
author Rahmani, Rana
Zarrini, Gholamreza
Sheikhzadeh, Farzam
Aghamohammadzadeh, Naser
author_facet Rahmani, Rana
Zarrini, Gholamreza
Sheikhzadeh, Farzam
Aghamohammadzadeh, Naser
author_sort Rahmani, Rana
collection PubMed
description BACKGROUND: Bacteriophages are viruses that attack bacteria and lead to their lysis in an efficient and highly specific manner. These natural enemies of bacteria were used as therapeutic agents before the advent of antibiotics. Currently, with the rapid spread of multi-drug resistant bacteria, phage therapy can be an effective alternative treatment for antibiotic resistant bacteria. OBJECTIVES: This study evaluated the effectiveness of bacteriophages in removing antibiotic-resistant clinical Escherichia coli strains in vitro and in vivo. PATIENTS AND METHODS: Different samples were taken from bed sore and foot ulcers of patients with diabetes. E. coli strains were isolated and identified by standard methods. The antibiogram was ascertained using the Kirby Bauer disc diffusion method for ten antibiotics. The bacteriophages were isolated from environmental water samples. They were exposed to the host bacteria by the double-layer agar technique (DLA) to observe plaques. Cross reaction of the phages on test E. coli strains was performed to determine broader-spectrum phages. Phage TPR7 was selected for animal trials. Five groups of mice including a control group, bacterial group, phage group, antibiotic therapy group and phage therapy group, were examined. RESULTS: Ten E. coli strains were isolated from hospital samples. They showed high resistance to the used antibiotics. An effective bacteriophage was isolated for each strain. The cross-reaction showed phages which affect more than six E. coli strains. They can be a good choice for clinical therapeutic use. In animal trials the group challenged with phages after being infected showed similar results as the group treated with gentamicin after being infected. In both groups infection was removed after 48 hours. CONCLUSIONS: According to the results, six strains were resistant to six or seven antibiotics and all strains were at least resistant to two antibiotics. However, for each of these resistant bacteria one bacteriophage was isolated from environmental samples, which showed the effectiveness of bacteriophages to remove clinically resistant E. coli strains. Effective phages in vitro showed effective results in vivo as well.
format Online
Article
Text
id pubmed-4377167
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-43771672015-04-01 Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli Rahmani, Rana Zarrini, Gholamreza Sheikhzadeh, Farzam Aghamohammadzadeh, Naser Jundishapur J Microbiol Research Article BACKGROUND: Bacteriophages are viruses that attack bacteria and lead to their lysis in an efficient and highly specific manner. These natural enemies of bacteria were used as therapeutic agents before the advent of antibiotics. Currently, with the rapid spread of multi-drug resistant bacteria, phage therapy can be an effective alternative treatment for antibiotic resistant bacteria. OBJECTIVES: This study evaluated the effectiveness of bacteriophages in removing antibiotic-resistant clinical Escherichia coli strains in vitro and in vivo. PATIENTS AND METHODS: Different samples were taken from bed sore and foot ulcers of patients with diabetes. E. coli strains were isolated and identified by standard methods. The antibiogram was ascertained using the Kirby Bauer disc diffusion method for ten antibiotics. The bacteriophages were isolated from environmental water samples. They were exposed to the host bacteria by the double-layer agar technique (DLA) to observe plaques. Cross reaction of the phages on test E. coli strains was performed to determine broader-spectrum phages. Phage TPR7 was selected for animal trials. Five groups of mice including a control group, bacterial group, phage group, antibiotic therapy group and phage therapy group, were examined. RESULTS: Ten E. coli strains were isolated from hospital samples. They showed high resistance to the used antibiotics. An effective bacteriophage was isolated for each strain. The cross-reaction showed phages which affect more than six E. coli strains. They can be a good choice for clinical therapeutic use. In animal trials the group challenged with phages after being infected showed similar results as the group treated with gentamicin after being infected. In both groups infection was removed after 48 hours. CONCLUSIONS: According to the results, six strains were resistant to six or seven antibiotics and all strains were at least resistant to two antibiotics. However, for each of these resistant bacteria one bacteriophage was isolated from environmental samples, which showed the effectiveness of bacteriophages to remove clinically resistant E. coli strains. Effective phages in vitro showed effective results in vivo as well. Kowsar 2015-02-20 /pmc/articles/PMC4377167/ /pubmed/25834712 http://dx.doi.org/10.5812/jjm.17744 Text en Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Rahmani, Rana
Zarrini, Gholamreza
Sheikhzadeh, Farzam
Aghamohammadzadeh, Naser
Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli
title Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli
title_full Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli
title_fullStr Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli
title_full_unstemmed Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli
title_short Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli
title_sort effective phages as green antimicrobial agents against antibiotic-resistant hospital escherichia coli
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377167/
https://www.ncbi.nlm.nih.gov/pubmed/25834712
http://dx.doi.org/10.5812/jjm.17744
work_keys_str_mv AT rahmanirana effectivephagesasgreenantimicrobialagentsagainstantibioticresistanthospitalescherichiacoli
AT zarrinigholamreza effectivephagesasgreenantimicrobialagentsagainstantibioticresistanthospitalescherichiacoli
AT sheikhzadehfarzam effectivephagesasgreenantimicrobialagentsagainstantibioticresistanthospitalescherichiacoli
AT aghamohammadzadehnaser effectivephagesasgreenantimicrobialagentsagainstantibioticresistanthospitalescherichiacoli